Novartis AG (NVS) Stock Forecast & Price Target
Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Novartis AG (NVS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Novartis AG, analysts forecast revenue rising from $55.47B in 2025 to $71.06B in 2030; the average estimate for 2030 earnings per share is $12.92; with published estimates ranging from $12.52 to $13.36; 13 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Novartis AG (NVS) forecast — frequently asked questions
What is the analyst price target for Novartis AG?
Analysts covering Novartis AG (NVS) have a consensus price target of $149.50, 6.1% below the current price of $159.19. Published targets range from $136.00 to $163.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Novartis AG's earnings?
The average analyst estimate for Novartis AG (NVS) earnings per share in 2030 is 12.92, with individual estimates between 12.52 and 13.36.
How much revenue is Novartis AG expected to make?
Analysts forecast Novartis AG (NVS) revenue of $71.06B in 2030, based on 6 published estimates.
How many analysts cover NVS?
13 analysts contribute estimates for Novartis AG (NVS). Thin coverage makes an average less reliable.
Analyst forecasts for other Drug Manufacturers - General stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.